vs

Side-by-side financial comparison of STANDARD BIOTOOLS INC. (LAB) and ONE LIBERTY PROPERTIES INC (OLP). Click either name above to swap in a different company.

ONE LIBERTY PROPERTIES INC is the larger business by last-quarter revenue ($24.7M vs $19.6M, roughly 1.3× STANDARD BIOTOOLS INC.). ONE LIBERTY PROPERTIES INC runs the higher net margin — 9.7% vs -177.4%, a 187.1% gap on every dollar of revenue. On growth, ONE LIBERTY PROPERTIES INC posted the faster year-over-year revenue change (3.7% vs -11.5%). Over the past eight quarters, ONE LIBERTY PROPERTIES INC's revenue compounded faster (4.4% CAGR vs -12.2%).

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

Liberty Media Corporation is an American mass media company founded by John C. Malone in 1991. The company has two divisions, represented by separate tracking stocks, reflecting its ownership stakes in the Formula One Group and Live Nation Entertainment. As of 2025, Liberty Media owned three global motorsport businesses in the form of Formula One, MotoGP and World Superbikes.

LAB vs OLP — Head-to-Head

Bigger by revenue
OLP
OLP
1.3× larger
OLP
$24.7M
$19.6M
LAB
Growing faster (revenue YoY)
OLP
OLP
+15.2% gap
OLP
3.7%
-11.5%
LAB
Higher net margin
OLP
OLP
187.1% more per $
OLP
9.7%
-177.4%
LAB
Faster 2-yr revenue CAGR
OLP
OLP
Annualised
OLP
4.4%
-12.2%
LAB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
LAB
LAB
OLP
OLP
Revenue
$19.6M
$24.7M
Net Profit
$-34.7M
$2.4M
Gross Margin
48.5%
Operating Margin
-168.5%
28.6%
Net Margin
-177.4%
9.7%
Revenue YoY
-11.5%
3.7%
Net Profit YoY
-28.8%
-77.1%
EPS (diluted)
$-0.09
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LAB
LAB
OLP
OLP
Q4 25
$24.7M
Q3 25
$19.6M
$23.8M
Q2 25
$21.8M
$24.5M
Q1 25
$40.8M
$24.2M
Q4 24
$23.9M
Q3 24
$22.1M
$22.2M
Q2 24
$22.5M
$21.8M
Q1 24
$45.5M
$22.7M
Net Profit
LAB
LAB
OLP
OLP
Q4 25
$2.4M
Q3 25
$-34.7M
$10.5M
Q2 25
$-33.5M
$8.4M
Q1 25
$-26.0M
$4.2M
Q4 24
$10.6M
Q3 24
$-26.9M
$5.2M
Q2 24
$-45.7M
$9.6M
Q1 24
$-32.2M
$5.2M
Gross Margin
LAB
LAB
OLP
OLP
Q4 25
Q3 25
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
LAB
LAB
OLP
OLP
Q4 25
28.6%
Q3 25
-168.5%
66.7%
Q2 25
-118.1%
62.6%
Q1 25
-80.8%
39.8%
Q4 24
65.0%
Q3 24
-120.9%
45.0%
Q2 24
-134.5%
66.0%
Q1 24
-132.2%
44.1%
Net Margin
LAB
LAB
OLP
OLP
Q4 25
9.7%
Q3 25
-177.4%
44.1%
Q2 25
-153.7%
34.3%
Q1 25
-63.8%
17.2%
Q4 24
44.1%
Q3 24
-122.0%
23.3%
Q2 24
-203.3%
43.8%
Q1 24
-70.6%
22.7%
EPS (diluted)
LAB
LAB
OLP
OLP
Q4 25
$0.10
Q3 25
$-0.09
$0.48
Q2 25
$-0.09
$0.39
Q1 25
$-0.07
$0.18
Q4 24
$0.49
Q3 24
$-0.07
$0.23
Q2 24
$-0.12
$0.45
Q1 24
$-0.27
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LAB
LAB
OLP
OLP
Cash + ST InvestmentsLiquidity on hand
$129.4M
$14.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$399.7M
$299.6M
Total Assets
$539.6M
$857.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LAB
LAB
OLP
OLP
Q4 25
$14.4M
Q3 25
$129.4M
$18.8M
Q2 25
$158.6M
$19.0M
Q1 25
$150.9M
$8.2M
Q4 24
$42.3M
Q3 24
$210.6M
$25.7M
Q2 24
$269.8M
$35.0M
Q1 24
$287.1M
$27.4M
Total Debt
LAB
LAB
OLP
OLP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
LAB
LAB
OLP
OLP
Q4 25
$299.6M
Q3 25
$399.7M
$305.6M
Q2 25
$424.5M
$303.4M
Q1 25
$454.6M
$303.2M
Q4 24
$307.4M
Q3 24
$489.3M
$304.2M
Q2 24
$510.3M
$307.3M
Q1 24
$577.3M
$304.8M
Total Assets
LAB
LAB
OLP
OLP
Q4 25
$857.6M
Q3 25
$539.6M
$802.3M
Q2 25
$557.0M
$795.6M
Q1 25
$579.6M
$811.7M
Q4 24
$767.0M
Q3 24
$681.5M
$768.8M
Q2 24
$708.7M
$759.2M
Q1 24
$777.7M
$755.7M
Debt / Equity
LAB
LAB
OLP
OLP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LAB
LAB
OLP
OLP
Operating Cash FlowLast quarter
$-22.2M
$37.5M
Free Cash FlowOCF − Capex
$-23.1M
FCF MarginFCF / Revenue
-118.1%
Capex IntensityCapex / Revenue
4.5%
Cash ConversionOCF / Net Profit
15.54×
TTM Free Cash FlowTrailing 4 quarters
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LAB
LAB
OLP
OLP
Q4 25
$37.5M
Q3 25
$-22.2M
$10.9M
Q2 25
$-20.7M
$11.2M
Q1 25
$-30.3M
$11.0M
Q4 24
$39.1M
Q3 24
$-27.9M
$10.0M
Q2 24
$-39.0M
$8.6M
Q1 24
$-62.5M
$8.9M
Free Cash Flow
LAB
LAB
OLP
OLP
Q4 25
Q3 25
$-23.1M
Q2 25
$-22.6M
Q1 25
$-35.3M
Q4 24
Q3 24
$-30.1M
Q2 24
$-41.0M
Q1 24
$-63.3M
FCF Margin
LAB
LAB
OLP
OLP
Q4 25
Q3 25
-118.1%
Q2 25
-103.6%
Q1 25
-86.6%
Q4 24
Q3 24
-136.4%
Q2 24
-182.2%
Q1 24
-138.9%
Capex Intensity
LAB
LAB
OLP
OLP
Q4 25
Q3 25
4.5%
Q2 25
8.7%
Q1 25
12.4%
Q4 24
Q3 24
10.2%
Q2 24
8.6%
Q1 24
1.7%
Cash Conversion
LAB
LAB
OLP
OLP
Q4 25
15.54×
Q3 25
1.04×
Q2 25
1.33×
Q1 25
2.65×
Q4 24
3.70×
Q3 24
1.93×
Q2 24
0.90×
Q1 24
1.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

OLP
OLP

Segment breakdown not available.

Related Comparisons